News from Guardant Health A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 16, 2017, 13:05 ET Guardant Health Expands Support for the Development of the GuardantOMNI™ Assay Through New Agreement with Bristol-Myers Squibb

Guardant Health has added Bristol-Myers Squibb Company to the group of pharmaceutical companies it is working with to develop the GuardantOMNI...


Nov 15, 2017, 15:03 ET New Research Reveals Molecular Heterogeneity of Metastatic Gastroesophageal Cancer

Researchers from the University of Chicago, Dana-Farber Cancer Institute (DFCI), and Guardant Health, Inc. published new evidence of the genomic...


Nov 06, 2017, 11:37 ET Guardant Health Database Reveals Potential of Targeted Therapy Combinations to Treat Advanced Lung Cancer

Research led by scientists at UC San Francisco and the Francis Crick Institute in London has used Guardant Health's database of comprehensive...


Oct 02, 2017, 11:00 ET Study Demonstrates Potential for the Guardant360 Assay® to Predict Which Patients Will Benefit from Immunotherapy

Oncologists may get a new tool for identifying which of their cancer patients are most likely to respond to widely prescribed immunotherapies,...


Sep 26, 2017, 09:00 ET Guardant Health Receives Investigational Device Exemption Approval from the FDA to Support Merck KGaA, Darmstadt, Germany Tepotinib Study

Guardant Health announced that it received an investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to...


Jun 27, 2017, 11:00 ET New Studies Demonstrate the Need for and Utility of Comprehensive Liquid Biopsies

Two recent studies demonstrate the unmet medical need for and the clinical utility of a highly sensitive comprehensive liquid biopsy to help manage...


Jun 22, 2017, 11:00 ET Guardant Health Files Lanham Act Lawsuit Against Foundation Medicine Alleging False Advertising

Guardant Health, the leader in comprehensive liquid biopsies, filed a lawsuit against Foundation Medicine, Inc. (FMI), for false advertising and...


Jun 03, 2017, 08:00 ET Guardant Health announces broad, long-term alliance with Pfizer Oncology supporting multiple clinical programs with the Guardant360 assay

Guardant Health announced a broad, long-term alliance with Pfizer Oncology to support several clinical trial programs. A non-exclusive agreement...


May 24, 2017, 12:00 ET New York State Issues Approval for the Guardant360 Assay

Guardant Health announced that the Guardant360® assay has been approved by New York State's Clinical Laboratory Evaluation Program (CLEP). The...


May 18, 2017, 09:00 ET Guardant Health Announces Draft Medicare Local Coverage Determination for the Guardant360 Assay

Guardant Health® announced that Palmetto GBA, a Medicare Administrative Contractor and leader in evaluating molecular diagnostic technology through...


May 11, 2017, 08:00 ET Guardant Health Partners with SoftBank to Accelerate Efforts in Early Cancer Detection

Guardant Health, the world leader in comprehensive liquid biopsies, announced an ambitious goal to sequence the tumor DNA of more than 1 million...


Jan 31, 2017, 09:12 ET MD Anderson and Guardant Health announce partnership to make comprehensive liquid biopsy part of oncology standard of care

The University of Texas MD Anderson Cancer Center and Guardant Health today announced a multi-year partnership designed to accelerate comprehensive...


Jan 06, 2017, 09:01 ET Guardant Health to create a new 500-plus-gene liquid biopsy panel with several leading pharmaceutical companies to accelerate clinical trials and drug development

Guardant Health today announced that it has entered into separate agreements with AstraZeneca, Merck (known as MSD outside the United States and...


Jan 06, 2017, 09:01 ET Ian Clark joins Guardant Health Board of Directors

Guardant Health Inc., the creator of the gold standard for comprehensive liquid biopsy, announced that Ian Clark has joined its board of directors....


Nov 16, 2016, 09:00 ET Guardant Health Announces Milestone Partnership with Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Guardant Health Inc. announced today a comprehensive partnership with Northwestern University that will make Guardant360 the preferred liquid...


Nov 03, 2016, 09:01 ET Guardant Health Announces Enhancements to Guardant360 Designed to Further Improve Clinical Sensitivity and Utility

Guardant Health announced enhancements to Guardant360, the gold standard for comprehensive liquid biopsy, to help oncologists provide the best...


Oct 17, 2016, 11:01 ET Guardant Health makes commitment to share expertise and data to advance Blood Profiling Atlas, part of White House Cancer Moonshot

Guardant Health announced today that it will contribute data from 500 advanced lung-cancer patients tested with Guardant360 to the Blood Profiling...


Sep 09, 2016, 10:05 ET Prospective, independent study demonstrates the utility of Guardant360 for guiding therapy selection in advanced Non-Small-Cell Lung Cancer

 A new prospective study of Guardant360® was published in Clinical Cancer Research, adding to the growing body of evidence demonstrating...


Jul 14, 2016, 09:00 ET Guardant Health Collaborates with OncoMed Pharmaceuticals on Anti-RSPO3 Clinical Trial

 Guardant Health, the leader in comprehensive liquid biopsies, announced a strategic collaboration with OncoMed Pharmaceuticals, a...


Jul 07, 2016, 09:00 ET Priority Health becomes first health plan to cover Guardant Health's comprehensive liquid biopsy, Guardant360®

 Guardant Health announced an agreement with Priority Health, one of Michigan's largest health plans, that will bring its comprehensive liquid...


Jun 06, 2016, 07:30 ET First prospective clinical utility trial using comprehensive liquid biopsy to guide metastatic cancer patients to molecularly matched therapies demonstrates comparable results to tissue-based testing

Guardant Health and Samsung Medical Center (Sungkyunkwan University School of Medicine, Korea) announced today the results of the first prospective...


Jan 07, 2016, 07:30 ET Guardant Health Secures Series D Financing to Expand the Reach of its Digital Sequencing™ Platform in Oncology

 Guardant Health, the leader in non-invasive cancer genomic sequencing, today announced it has completed a first closing on the majority of a...


Dec 02, 2015, 06:00 ET Guardant Health and Labco Quality Diagnostics (synlab Group) Announce Joint International Expansion

 Guardant Health, the leader in liquid biopsies, announced today that will accelerate the international commercialization of its...


Nov 09, 2015, 07:00 ET Guardant Health® and Collaborators Present Further Clinical Utility Data for Guardant360® at the AACR-NCI-EORTC International Conference On Molecular Targets and Cancer Therapeutics

 Guardant Health®, the leader in liquid biopsies, announced today the presentation of eight scientific posters by collaborators from...


Oct 20, 2015, 12:00 ET New studies show the power of comprehensive, non-invasive solid-tumor genomic testing with Guardant360®

 Guardant Health®, the leader in liquid biopsies, announced the publication of two peer-reviewed studies demonstrating the superior...